NPs Basic Information

Name
Quinolactacin A1
Molecular Formula C16H18N2O2
IUPAC Name*
(3R)-3-[(2S)-butan-2-yl]-4-methyl-2,3-dihydropyrrolo[3,4-b]quinoline-1,9-dione
SMILES
CC[C@H](C)[C@@H]1C2=C(C(=O)C3=CC=CC=C3N2C)C(=O)N1
InChI
InChI=1S/C16H18N2O2/c1-4-9(2)13-14-12(16(20)17-13)15(19)10-7-5-6-8-11(10)18(14)3/h5-9,13H,4H2,1-3H3,(H,17,20)/t9-,13+/m0/s1
InChIKey
FLHQAMWKNPOTDV-TVQRCGJNSA-N
Synonyms
Quinolactacin A1; (+)-Quinolactacin A1; 815576-68-2; (3R)-2,3-dihydro-4-methyl-3-[(1S)-1-methylpropyl]-1H-pyrrolo[3,4-b]quinoline-1,9(4H)-dione; HY-N7480A; ZINC14684867; CS-0136107; (3R)-3-[(2S)-butan-2-yl]-4-methyl-2,3-dihydropyrrolo[3,4-b]quinoline-1,9-dione
CAS NA
PubChem CID 26202199
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Quinolines and derivative
        • Subclass: Pyrroloquinolines
          • Direct Parent: Pyrroloquinolines

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 270.33 ALogp: 2.5
HBD: 1 HBA: 3
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 49.4 Aromatic Rings: 3
Heavy Atoms: 20 QED Weighted: 0.911

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.741 MDCK Permeability: 0.00001850
Pgp-inhibitor: 0.049 Pgp-substrate: 0.879
Human Intestinal Absorption (HIA): 0.006 20% Bioavailability (F20%): 0.01
30% Bioavailability (F30%): 0.112

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.946 Plasma Protein Binding (PPB): 80.68%
Volume Distribution (VD): 1.469 Fu: 10.49%

ADMET: Metabolism

CYP1A2-inhibitor: 0.918 CYP1A2-substrate: 0.824
CYP2C19-inhibitor: 0.411 CYP2C19-substrate: 0.809
CYP2C9-inhibitor: 0.497 CYP2C9-substrate: 0.534
CYP2D6-inhibitor: 0.173 CYP2D6-substrate: 0.276
CYP3A4-inhibitor: 0.531 CYP3A4-substrate: 0.212

ADMET: Excretion

Clearance (CL): 2.275 Half-life (T1/2): 0.115

ADMET: Toxicity

hERG Blockers: 0.013 Human Hepatotoxicity (H-HT): 0.217
Drug-inuced Liver Injury (DILI): 0.251 AMES Toxicity: 0.872
Rat Oral Acute Toxicity: 0.158 Maximum Recommended Daily Dose: 0.8
Skin Sensitization: 0.087 Carcinogencity: 0.889
Eye Corrosion: 0.004 Eye Irritation: 0.196
Respiratory Toxicity: 0.352
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC002158 0.522 D06GKN 0.356
ENC004684 0.430 D0K7WK 0.356
ENC004688 0.425 D05EPM 0.329
ENC004691 0.425 D07RGW 0.320
ENC004686 0.423 D08UMH 0.316
ENC004693 0.423 D0J6WW 0.295
ENC004267 0.389 D06IXT 0.295
ENC002809 0.379 D06BYV 0.288
ENC005470 0.368 D03GET 0.282
ENC005998 0.360 D08EOD 0.280
*Note: the compound similarity was calculated by RDKIT.